dc.contributorKatz, Samuel G.
dc.contributorRabinovich, Peter M.
dc.creatorDomaica, Carolina Ines
dc.creatorSierra, Jessica Mariel
dc.creatorZwirner, Norberto Walter
dc.creatorFuertes, Mercedes Beatriz
dc.date.accessioned2021-09-19T17:30:06Z
dc.date.accessioned2022-10-15T01:35:30Z
dc.date.available2021-09-19T17:30:06Z
dc.date.available2022-10-15T01:35:30Z
dc.date.created2021-09-19T17:30:06Z
dc.date.issued2020
dc.identifierDomaica, Carolina Ines; Sierra, Jessica Mariel; Zwirner, Norberto Walter; Fuertes, Mercedes Beatriz; Immunomodulation of NK cell activity; Humana press; 2097; 2020; 125-136
dc.identifier978-1-0716-0203-4
dc.identifierhttp://hdl.handle.net/11336/140793
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4330618
dc.description.abstractNatural killer (NK) cells can kill virus-infected cells and tumor cells without prior sensitization and secrete numerous cytokines and chemokines that modulate the activity of different cells of the immune system. The recognition of target cells is mediated by germ line-encoded receptors, and the activity of NK cells can be further regulated by soluble factors such as cytokines and Toll-like receptor ligands. Thus, NK cells display an exciting potential as a powerful immunotherapeutic tool against malignant diseases, and different strategies are being tested aiming to overcome tumor-induced NK cell suppression and restore NK-cell mediated antitumor activity. This section describes different flow cytometry-based protocols to study NK cell effector functions, which can be used to evaluate the immunomodulatory ability of different therapeutic compounds.
dc.languageeng
dc.publisherHumana press
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://link.springer.com/protocol/10.1007%2F978-1-0716-0203-4_9
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1007/978-1-0716-0203-4_9
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.sourceCell reprogramming for immunotherapy
dc.subjectNK CELLS
dc.subjectCYTOKINES
dc.subjectCYTOTOXICITY
dc.titleImmunomodulation of NK cell activity
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeinfo:eu-repo/semantics/bookPart
dc.typeinfo:ar-repo/semantics/parte de libro


Este ítem pertenece a la siguiente institución